Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001209191-21-022204

CEO and Chairman sold 15,000 shares at an average $42.89 ($643,416)

From the SEC's structured data for this filing

Trades in this filing

ROBINS CHAD M · CEO and Chairman

Table I: Non-derivative

8 lines
Date Transaction Shares Price Value Owned after D/I
2021-03-17 Sale : show line 1 in the form −1,901 $43.22 $82,161 1,776,560 D
2021-03-17 Sale : show line 2 in the form −1,295 $44.03 $57,019 1,775,265 D
2021-03-17 Sale : show line 3 in the form −1,804 $45.25 $81,631 1,773,461 D
2021-03-18 Sale : show line 4 in the form −1,926 $41.90 $80,699 1,771,535 D
2021-03-18 Sale : show line 5 in the form −2,604 $42.81 $111,477 1,768,931 D
2021-03-18 Sale : show line 6 in the form −470 $43.78 $20,577 1,768,461 D
2021-03-19 Sale : show line 7 in the form −4,900 $41.96 $205,604 1,763,561 D
2021-03-19 Sale : show line 8 in the form −100 $42.48 $4,248 1,763,461 D
Open-market sales · 15,000 sh · avg $42.89 · $643,416
Loading xslF345X03/doc4.xml…